I. Anghelescu

发表

Comparison of Hypericum Extract WS® 5570 and Paroxetine in Ongoing Treatment after Recovery from an Episode of Moderate to Severe Depression: Results from a Randomized Multicenter Study

A. Szegedi, R. Kohnen, M. Kieser, 2006, Pharmacopsychiatry.

Activity of the adenylyl cyclase in lymphocytes of male alcoholic patients is state dependent.

N. Dahmen, M. Müller, A. Szegedi, 1998, Alcoholism, clinical and experimental research.

Pharmacokinetic interactions of clozapine with selective serotonin reuptake inhibitors: differential effects of fluvoxamine and paroxetine in a prospective study.

A. Szegedi, H. Wetzel, I. Anghelescu, 1998, Journal of clinical psychopharmacology.

Combination treatment with clozapine and paroxetine in schizophrenia: safety and tolerability data from a prospective open clinical trial

A. Szegedi, H. Wetzel, I. Anghelescu, 1998, European Neuropsychopharmacology.

Combination treatment with nefazodone and cognitive-behavioral therapy for relapse prevention in alcohol-dependent men: a randomized controlled study.

Matthias J. Müller, T. Wobrock, A. Scheurich, 2004, The Journal of clinical psychiatry.

Carbohydrate-deficient transferrin (CDT) and HDL cholesterol (HDL) are highly correlated in male alcohol dependent patients.

A. Szegedi, H. Wetzel, H. Himmerich, 2000, Alcoholism, clinical and experimental research.

No association of alcohol dependence with a NMDA-receptor 2B gene variant

D. Rujescu, I. Giegling, S. Wiemann, 2003, Molecular Psychiatry.

Reliability and validity of the German version of the European Addiction Severity Index (EuropASI).

Matthias J. Müller, A. Scheurich, M. Hautzinger, 2000, Journal of studies on alcohol.

Sex differences in allelic frequencies of the 5‐HT2C Cys23Ser polymorphism in psychiatric patients and healthy volunteers: findings from an association study

N. Dahmen, A. Szegedi, I. Anghelescu, 2000, Psychiatric genetics.

No association between the dopamine d2 receptor taqi a1 allele and earlier age of onset of alcohol dependence according to different specified criteria.

N. Dahmen, A. Szegedi, H. Wetzel, 2001, Alcoholism, clinical and experimental research.

Adenylyl cyclase activity is increased in younger, but decreased in older, alcoholic patients after detoxification.

N. Dahmen, A. Szegedi, H. Wetzel, 2000, Alcohol and alcoholism.

Alcohol dependence is associated with a NMDA-receptor 2B gene variant

D. Rujescu, I. Giegling, S. Wiemann, 2001, European Psychiatry.

Genetic polymorphisms of the dopamine D2 and D3 receptor and neuroleptic drug effects in schizophrenic patients

Matthias J. Müller, D. Rujescu, H. Wetzel, 2001, Schizophrenia Research.

Long-Term Effects of the Substituted Benzamide Derivative Amisulpride on Baseline and Stimulated Prolactin Levels

R. Schlösser, O. Benkert, G. Gründer, 2002, Neuropsychobiology.

Addition of Low-Dose Fluvoxamine to Low-Dose Clozapine Monotherapy in Schizophrenia: Drug Monitoring and Tolerability Data from a Prospective Clinical Trial

A. Szegedi, H. Wetzel, I. Anghelescu, 1999, Pharmacopsychiatry.

Neuropsychological status of alcohol-dependent patients: increased performance through goal-setting instructions.

Matthias J. Müller, A. Scheurich, M. Hautzinger, 2004, Alcohol and alcoholism.

Vitamin B12 and hepatic enzyme serum levels correlate in male alcohol-dependent patients.

A. Szegedi, H. Himmerich, I. Anghelescu, 2001, Alcohol and alcoholism.

Furosemide action on cerebellar GABA(A) receptors in alcohol-sensitive ANT rats.

H. Alho, I. Anghelescu, S. Oja, 1999, Alcohol.

Topiramate in venlafaxine-induced visual hallucinations in an obese patient with a posterior cerebral artery infarction.

A. Szegedi, H. Himmerich, I. Anghelescu, 2001, Journal of clinical psychopharmacology.

[Combination treatment with SSRI and cognitive behavior therapy for relapse prevention of alcohol-dependent men. Results of a randomized, controlled multicenter therapeutic study].

T. Wobrock, A. Scheurich, M. Hautzinger, 2005, Der Nervenarzt.

Neuroendocrine response to antipsychotics: effects of drug type and gender

R. Schlösser, H. Wetzel, O. Benkert, 1999, Biological Psychiatry.

A prepro-orexin gene polymorphism is associated with narcolepsy

N. Dahmen, A. Szegedi, J. Bierbrauer, 2001, Neurology.

Analysis of genetic variations of protein tyrosine kinase fyn and their association with alcohol dependence in two independent cohorts

D. Rujescu, I. Giegling, A. Poustka, 2003, Biological Psychiatry.

Reliability and Validity of the Form 90 Interview

A. Scheurich, M. Hautzinger, A. Szegedi, 2004, European Addiction Research.

Predicting Response to Psychopharmacological Treatment: Survey of Recent Results

D. Rujescu, H. Stassen, A. Szegedi, 2011, Pharmacopsychiatry.

Placebo controlled continuation treatment with Hypericum extract WS® 5570 after recovery from a mild or moderate depressive episode

S. Kasper, A. Szegedi, A. Dienel, 2007, Wiener Medizinische Wochenschrift.

Polymorphisms in the NMDA subunit 2B are not associated with alcohol dependence and alcohol withdrawal–induced seizures and delirium tremens

D. Rujescu, I. Giegling, N. Dahmen, 2005, European Archives of Psychiatry and Clinical Neuroscience.

Normal PET after long-term ECT.

A. Szegedi, I. Anghelescu, C. Klawe, 2001, The American journal of psychiatry.

Association Study of Suicidal Behavior and Affective Disorders with a Genetic Polymorphism in ABCG1, a Positional Candidate on Chromosome 21q22.3

D. Rujescu, I. Giegling, A. Gietl, 2000 .

Association study of suicidal behavior and affective disorders with a genetic polymorphism in ABCG1, a positional candidate on chromosome 21q22.3

D. Rujescu, I. Giegling, H. Möller, 2000, European Neuropsychopharmacology.

Carbohydrate-deficient transferrin (CDT) and HDL cholesterol (HDL) are highly correlated in male alcohol dependent patients.

I. Anghelescu, Matthias J. Müller, Armin Szegedi, 2000, Alcoholism, clinical and experimental research.